The LifeSite Hemodialysis Access System appears to offer significant advantage over tunneled catheters with regard to reduced infection, reduced thrombosis, and, ultimately, device survival.
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
Tunneled cuffed catheters (TCCs) are frequently the only vascular access option for hemodialysis patients with diabetes, because of these patients' compromised vasculature. TCCs are, however ...
The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback